Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Colorcon
Julphar
AstraZeneca
Argus Health
Cipla
Cantor Fitzgerald
Farmers Insurance

Generated: December 15, 2018

DrugPatentWatch Database Preview

BENDEKA Drug Profile

« Back to Dashboard

Which patents cover Bendeka, and what generic alternatives are available?

Bendeka is a drug marketed by Eagle Pharms and is included in one NDA. There are fifteen patents protecting this drug and one Paragraph IV challenge.

This drug has sixty-four patent family members in thirty-one countries.

The generic ingredient in BENDEKA is bendamustine hydrochloride. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.

Drug patent expirations by year for BENDEKA
Pharmacology for BENDEKA
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for BENDEKA
Synonyms for BENDEKA
16506-27-7
16506-27-7 (Parent)
1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-
1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride
1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride (9CI)
1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl monohydrochloride
1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride
1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride (1:1)
1H-Benzimidazole-2-butanoic acid, monohydrochloride
1H-Benzimidazole-2-butanoic acid,5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride
1H-Benzimidazole-2-butanoicacid, 5-[bis(2-chloroethyl)amino]-1-methyl-
1H-Benzimidazole-2-butanoicacid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride (1:?)
2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-
2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride
2-Benzimidazolebutyric acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, monohydrochloride (8CI)
2-Benzimidazolebutyric acid, monohydrochloride
2-Benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride
2-Benzimidazolinebutryric acid, hydrochloride
3543-75-7
3543-75-7 (hydrochloride)
3B1-009307
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo-[d]imidazol-2-yl)butanoic acid hydrochloride
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid hydrochloride
4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid hydrochloride
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid hydrochloride
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride
4-{5-[bis(2-chlorethyl)amino]-1-methyl-1h-benzimidazol-2-yl}butans
4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid hydrochloride
4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
4CA-0265
4CA-0266
5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid hydrochloride
5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazole-2-butyric Acid Hydrochloride
506B277
543B757
9266D9P3PQ
97832-05-8
981Y8SX18M
AB0017997
AB01273966_03
AB01273966-01
AB01273966-02
AB1008551
ABP000613
AC-1619
AC-22488
AC1L23NB
AC1L2SBO
AC1Q3BIE
ACN-040196
AK-60966
AK-94013
AKOS015951203
AKOS022181343
AM20090666
AN-34706
AN-664
ANW-58063
API0002176
API0005688
AS-15856
B4033
BC645220
BC684636
BCP0726000100
BCP9000389
BCP9000390
BCPP000348
BDBM173621
Benda
bendamustin
Bendamustin hydrochloride
Bendamustina
Bendamustina [Spanish]
Bendamustine
Bendamustine (hydrochloride)
Bendamustine (INN)
Bendamustine [INN:BAN]
Bendamustine [INN]
Bendamustine HCl
Bendamustine HCL (SDX-105, Cytostasane)
Bendamustine hydrochloride
Bendamustine hydrochloride (JAN/USAN)
Bendamustine hydrochloride [USAN:JAN]
Bendamustine Hydrochloride Injection
Bendamustine Hydrochloride/
Bendamustinehydrochloride
Bendamustinum
Bendamustinum [Latin]
Bendit
C-23733
C16H22Cl3N3O2
CAS-16506-27-7
CC-24269
CCG-221927
CCRIS 1864
CHEBI:135515
CHEMBL1201734
CHEMBL487253
CS-1771
CTK0H6928
CTK3I6647
Cytostasan
Cytostosan
D01CYA
D07085
D07501
DB06769
DD63046000
DSSTox_CID_26888
DSSTox_GSID_46888
DSSTox_RID_81991
DTXSID2046888
DTXSID40188912
FT-0080832
FT-0650624
FT-0696296
FT-0742187
gamma-(1-methyl-5-bis(beta-chloroethyl)aminobenzimidazole)-(2)-butyric acid
gamma(1-Methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid
gamma(1-Methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid [German]
GP6515
GTPL7478
HE064403
HE066504
HE420430
HSDB 7763
HY-B0077
IMET 3393
IN2037
InChI=1/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23
Inno-P08001
Innomustine
J-010179
KB-289694
KS-00000FOM
Levact
LP00623
LS-173588
LS-32675
LS-33224
MFCD00866481
MFCD16879055
MLS006010156
MolPort-003-844-702
MolPort-006-823-040
NCGC00181170-01
NCGC00181170-02
NCGC00181170-03
NCGC00261308-01
NIOSH/DD6304600
NSC 138783
NSC-138783
NSC138783
omega-(1-Methyl-5-bis(beta-chloroethyl)aminobenzimidazole-(2)-butyric acid
Ribomustin
Ribomustin (TN)
Ribomustine
s1212
SC-19231
SC-24142
SCHEMBL18843
SCHEMBL26319
SDX 105
SDX-105
SMR004234484
ST24042979
ST24042980
SyB L-0501
Symbenda
TC-010264
Tox21_112771
Tox21_112771_1
Tox21_500623
Treakisym
Treanda
Treanda (TN)
TX-012243
UNII-9266D9P3PQ
UNII-981Y8SX18M
US9096627, CY190602
WLN: T56 BN DNJ B1 C3VQ GN2G2G &GH
YTKUWDBFDASYHO-UHFFFAOYSA-N
ZHSKUOZOLHMKEA-UHFFFAOYSA-N
ZIMET 33/93
Zimet 3393
ZINC4214955

US Patents and Regulatory Information for BENDEKA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eagle Pharms BENDEKA bendamustine hydrochloride SOLUTION;IV (INFUSION) 208194-001 Dec 7, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Eagle Pharms BENDEKA bendamustine hydrochloride SOLUTION;IV (INFUSION) 208194-001 Dec 7, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Eagle Pharms BENDEKA bendamustine hydrochloride SOLUTION;IV (INFUSION) 208194-001 Dec 7, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for BENDEKA
Drugname Dosage Strength RLD Date
➤ Subscribe Injection 100 mg/4 mL (25 mg/mL) multiple-dose vials ➤ Subscribe ➤ Try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Colorcon
Julphar
AstraZeneca
Argus Health
Cipla
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.